Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 22, 2016

Primary Completion Date

December 12, 2017

Study Completion Date

March 20, 2018

Conditions

Acute Toxic EffectsTumor Responses

Interventions

DRUG

Lobaplatin

Lobaplatin for Injection

DEVICE

linear accelerator

Medical linear accelerator

Trial Locations (1)

the Fifth Hospital Affiliated to Sun Yat-Sen University, Zhuhai

All Listed Sponsors

lead

Fifth Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT03188497 - Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial | Biotech Hunter | Biotech Hunter